Boston Scientific accounts are for healthcare professionals only.
CAUTION: Federal law (USA) restricts this device to sale by or on the order of a physician.
Prior to use, please refer to all applicable “Instructions for Use” for more information on Intended Use/Indications for Use, Contraindications, Warnings, Precautions, Potential Adverse Events, and Operator’s Instructions.
- Express™ SD Renal Monorail™ Premounted Stent System
- Express™ SD BIiliary Monorail™ Premounted Stent System
Express SD Renal
Intended Use / Indications for use
The Express SD Renal Monorail Premounted Stent System is indicated for use as an adjunct to percutaneous transluminal renal angioplasty (PTRA) of a single de novo or restenotic atherosclerotic lesion (≤ 15 mm in length) of the renal artery, located within 5 mm of the opacified aortic lumen and with a reference vessel diameter of 4.0 mm to 7.0 mm to assist in maintenance of vessel patency.
Contraindications
Generally, contraindications for Percutaneous Transluminal Renal Angioplasty (PTRA) are also contraindications for stent placement. Contraindications associated with the use of the Express SD Renal Monorail Premounted Stent System include:
- Patients with uncorrected bleeding disorders or patients who cannot receive anticoagulation or antiplatelet aggregation therapy
- Persons with known allergies to stainless steel or its components (for example nickel)
- A lesion that is within or adjacent to the proximal or distal segments of an aneurysm
- Patients with a target lesion with a large amount of adjacent acute or subacute thrombus
- Patients with excessive vessel tortuosity
- Patients with perforated vessels evidenced by extravasation of contrast media
- Patients with a lesion that cannot be crossed with a wire and/or a balloon catheter
Warnings
Contents supplied STERILE using an ethylene oxide (EO) process. Do not use if sterile barrier is damaged. If damage is found, call your Boston Scientific representative.
For single patient use only. Do not reuse, reprocess or resterilize. Reuse, reprocessing or resterilization may compromise the structural integrity of the device and/or lead to device failure which, in turn, may result in patient injury, illness or death. Reuse, reprocessing or resterilization may also create a risk of contamination of the device and/or cause patient infection or cross-infection, including, but not limited to, the transmission of infectious disease(s) from one patient to another. Contamination of the device may lead to injury, illness or death of the patient.
After use, dispose of product and packaging in accordance with hospital, administrative and/or local government policy.
- Do not exceed the maximum rated burst pressure.
- As with any type of intravascular implant, infection, secondary to contamination of the stent, may lead to thrombosis, pseudoaneurysm or rupture into a neighboring organ or into the retroperitoneum.
- The stent may cause thrombus or distal emboli to migrate from the site of the implant down the arterial lumen.
- When stenting the renal arteries, exercise great care to reduce the risk of plaque embolization.
- Do not exceed the maximum expanded stent diameter.
- To reduce the potential for vessel damage, the inflated diameter of the balloon should approximate the diameter of the vessel just distal to the stenosis. Overstretching of the artery may result in rupture and life-threatening bleeding.
- Use only diluted contrast medium for balloon inflation (typically a 50/50 mixture by volume of contrast medium and normal saline). Never use air or any gaseous medium in the balloon.
- Persons with allergic reactions to stainless steel or its components (for example nickel) may suffer an allergic response.
- Do not expose the premounted stent system to organic solvents (i.e. alcohol)
- Patients with lesions in arteries of transplanted or bypassed kidneys are not recommended for stent implantation.
- The long-term outcome (beyond nine months) for this permanent implant is unknown at present.
- Stent placement should only be performed at hospitals where emergency peripheral artery bypass graft surgery, including renal artery bypass graft surgery, can be readily performed.
Precautions
- The device is intended for use by physicians who have experience in interventional techniques such as percutaneous transluminal angioplasty (PTA) and placement of intravascular stents.
- The sterile packaging and device should be inspected prior to use. If sterility or performance of the device is suspect, it should not be used.
- Caution should be taken with patients with poor renal function who, in the physician’s opinion, may be at risk for a contrast medium reaction. Note: Patients with serum creatinine ≥3.0 mg/dl were excluded from the Renaissance clinical study.
- Prep premounted stent system per instructions given in Operational Instructions. Significant amounts of air in the balloon may cause difficulty in deploying the stent and deflation of the balloon.
- Do not attempt to pull a stent where deployment has been initiated back through a sheath or guide catheter, since dislodgment of the stent may result. If a stent that has not been fully deployed needs to be removed, the sheath or guide catheter and the premounted stent system should be removed as a unit.
- The SDS is not designed for use with power injection systems. Inflation at a high rate can cause damage to the balloon. Use of a pressure monitoring device is recommended to prevent over pressurization.
- Do not attempt to manually remove or adjust the stent on the SDS balloon.
- The minimally acceptable sheath and guide catheter French size is printed on the package label. Do not attempt to pass the premounted stent system catheter through a smaller size sheath or guide catheter than indicated on the label.
- When a premounted stent system or SDS balloon is in the body, it should be manipulated only under fluoroscopy. Do not advance or retract the catheter unless the balloon is fully deflated under vacuum.
- Never advance the premounted stent system without the guidewire extending from the tip.
- Prior to completion of the procedure, utilize fluoroscopy to ensure proper positioning of the stent. If the target lesion is not fully covered, use an additional stent as necessary to adequately treat the lesion.
- It is recommended that when stenting multiple lesions, the distal lesions should be initially stented, followed by stenting of the proximal lesion. Stenting in this order obviates the need to cross the proximal stent when placing the distal stent and reduces the chances for disrupting the proximal stent.
- Prior to stent expansion, utilize fluoroscopy to verify the stent has not been damaged or dislodged during positioning. Expansion of the stent should not be undertaken if the stent is not appropriately positioned in the vessel. If the position of the stent is not optimal, it should not be expanded.
- To assure full expansion, inflate the premounted stent system to at least the opening pressure as shown on the labeling and in Table 1. To assure nominal sizing of the stent, inflate the premounted stent system to nominal pressure as shown on the labeling and in Table 1.
- Stenting across a bifurcation or side branch could compromise future diagnostic or therapeutic procedures, or could result in thrombosis of the side branch.
- More than one stent per lesion should only be used when clinically indicated for suboptimal results that compromise vessel integrity and threaten vessel closure. The second implanted stent should also be an Express SD Renal Stent, or a stent of similar material composition, for component compatibility.
- Do not attempt to reposition a partially deployed stent. Attempted repositioning may result in severe vessel damage. Incomplete deployment of the stent (i.e. stent not fully opened) may cause complications resulting in patient injury.
- Recrossing a previously deployed stent with adjunct devices must be performed with extreme caution to ensure that the stent does not get caught within previously placed stent struts.
- In the event of thrombosis of the expanded stent, thrombolysis and PTRA should be attempted.
- In the event of complications such as infections, pseudoaneurysm, or fistulization, surgical removal of the stent may be required.
- Use prior to the “Use By” date.
Adverse events
Potential complications associated with the use of vascular stents may include, but are not limited to:
- Abscess
- Acute myocardial infarction
- Acute or sub acute thrombosis
- Aneurysm
- Arrhythmias, including VF and VT
- Artery injury, including perforation and dissection
- AV fistula
- Bowel infarct
- Death
- Drug reaction, allergic reaction to contrast medium
- Emboli or air
- Embolization of atherosclerotic thrombotic materials
- Emergency surgery to correct vascular complications
- Extremity ischemia/amputation
- GI symptoms from anticoagulation/antiplatelet medication
- ·Hemorrhage/Hematoma
- Hypotension or Hypertension
- Intimal tear
- Kidney infarct
- Nephrectomy
- Pseudoaneurysm formation
- Renal failure
- Restenosis of the stented artery
- Rupture of retro-peritoneum or of neighboring organ
- Rupture, overstretching of vessel
- Sepsis/Infection
- Stent embolization
- Stent migration
- Stent misplacement
- Stroke or other cerebrovascular accidents
- Thromboembolic event
- Tissue necrosis
- Total occlusion
Express SD Biliary
Intended Use / Indications for use
The Express SD Biliary Monorail Premounted Stent System is indicated for palliation of malignant neoplasms in the biliary tree.
Contraindications
Contraindications associated with the use of the Express SD Biliary Monorail Premounted Stent System as a transhepatic endoprosthesis include:
- Stenting of a perforated duct where leakage from the duct could be exacerbated by the prosthesis.
- Patients with bleeding disorders.
- Severe ascites.
Warnings
Contents supplied STERILE using an ethylene oxide (EO) process. Do not use if sterile barrier is damaged. If damage is found, call your Boston Scientific representative.
For single patient use only. Do not reuse, reprocess or resterilize. Reuse, reprocessing or resterilization may compromise the structural integrity of the device and/or lead to device failure which, in turn, may result in patient injury, illness or death. Reuse, reprocessing or resterilization may also create a risk of contamination of the device and/or cause patient infection or cross-infection, including, but not limited to, the transmission of infectious disease(s) from one patient to another. Contamination of the device may lead to injury, illness or death of the patient. After use, dispose of product and packaging in accordance with hospital, administrative and/or local government policy.
- Use only diluted contrast medium for balloon inflation (typically a 50/50 mixture by volume of contrast medium and normal saline). Never use air or any gaseous medium in the balloon.
- Prepare Premounted Stent System per instructions given. Significant amounts of air in the balloon may cause difficulty in deploying the stent and deflation of the balloon.
- Do not exceed the maximum rated burst pressure.
- Persons with allergic reactions to stainless steel may suffer an allergic response to the implant.
- Do not expose the Premounted Stent System to organic solvents (i.e. alcohol).
- To reduce the potential for damage to the duct, the inflated diameter of the balloon should approximate the diameter of the duct just proximal and distal to the stricture. Overstretching of the duct may result in patient injury.
- Stenting across a bifurcation could compromise future diagnostic or therapeutic procedures.
Precautions
- The device is intended for use by physicians who have appropriate experience.
- The sterile packaging and device should be inspected prior to use. If sterility or performance of the device is suspect, it should not be used.
- Do not attempt to pull a stent that has not been expanded back through an introducer sheath, since dislodgment of the stent may result. If a stent that has not been expanded needs to be removed, the introducer sheath and the Premounted Stent System should be removed as a unit.
- When treating multiple strictures, the stricture distal to the puncture site should be initially stented, followed by stenting of the proximal stricture. Stenting in this order eliminates the need to cross the proximal stent to achieve placement of the distal stent, and reduces the chance for dislodging the proximal stent with the SDS balloon or Premounted Stent System or dislodging the stent from the SDS balloon.
- The Premounted Stent System is not designed for use with power injection systems. Inflation at a high rate can cause damage to the balloon. Use of a pressure monitoring device is recommended to prevent over pressurization.
- Do not attempt to manually remove or adjust the stent on the SDS balloon.
- The minimally acceptable introducer sheath French size is printed on the package label. Do not attempt to pass the pre-mounted stent system through a smaller size introducer sheath than indicated on the label.
- When catheters are in the body, they should be manipulated only under fluoroscopy. Do not advance or retract the catheter unless the balloon is fully deflated under vacuum.
- Never advance the Premounted Stent System without the guidewire extending from the tip.
- Prior to completion of the procedure, utilize fluoroscopy to ensure proper positioning of the stent. If the target stricture is not fully covered, use additional stents as necessary to adequately treat the stricture.
- To ensure expansion of the premounted stent, inflate the Premounted Stent System to at least the opening pressure as shown on the label. To assure nominal sizing of the stent, inflate the Premounted Stent System to nominal pressure as shown on the label.
- Prior to stent expansion, utilize high-resolution fluoroscopy to verify the stent has not been damaged or dislodged during positioning. Expansion of the stent should not be undertaken if the stent is not appropriately positioned in the duct. If the position of the stent is not optimal, it should not be expanded.
- Do not attempt to reposition a partially deployed stent. Attempted repositioning may result in patient injury. Incomplete deployment of the stent (i.e. stent not fully opened) may cause complications resulting in patient injury.
- Recrossing a previously deployed stent with adjunct devices must be performed with extreme caution.
- In the event of complications (such as infections), surgical removal of the stent may be required. Standard surgical procedure is appropriate.
- When multiple stents are required, if placement results in metal to metal contact, stent materials should be of similar composition.
Adverse events
Potential complications associated with biliary stenting may include, but are not limited to:
- Abscess
- Bile duct injury, including perforation, rupture and dissection
- Cholangitis
- Death
- Drug reaction, allergic reaction to contrast medium
- Hemobilia
- Hemorrhage/Hematoma
- Pancreatitis
- Parenchymal hemorrhage
- Peritonitis
- Sepsis/infection
- Stent migration
- Stent misplacement
- Stent obstruction secondary to tumor growth through the stent
- Total occlusion/obstruction
- Tumor overgrowth at the stent ends
Additional cautions
Do not attempt to manually reposition the premounted stent in any way. Check for bends, kinks and other damage. Do not use if any defects are noted.
Always use an appropriately sized sheath for the implant procedure. It is advisable to use a sheath or guide catheter that is long enough to cross the lesion. Use of a guide sheath or guide catheter minimizes the risk of dislodging the stent from the balloon during tracking.
If resistance is encountered to the premounted stent system prior to exiting the sheath or guide catheter, do not force passage. Resistance may indicate a problem and may result in damage or dislodgement of the stent if forced.
Maintain guidewire placement across the lesion and remove the premounted stent system with sheath or guide catheter as a single unit.
If strong resistance is met during advancement of the premounted stent system, discontinue movement and determine the cause of the resistance before proceeding. If the cause of resistance cannot be determined, withdraw both the premounted stent system and sheath or guide catheter as a single unit.
Allow adequate time for the balloon to fully deflate prior to removal. Observe fluoroscopically that the balloon is fully deflated prior to removal.
If resistance is encountered upon attempted removal, do not force removal, use fluoroscopy and conventional techniques to determine and remedy the cause of resistance before proceeding.
90960645 AE.3